The presentation discusses the potential of blockchain and AI to revolutionize the pharmaceutical supply chain. The author, with a rich history in healthcare technology, highlights the inefficiencies and challenges faced by the industry, particularly in areas like drug discovery, manufacturing, and distribution.   Blockchain technology, with its ability to create immutable records, can enhance transparency, traceability, and security across the supply chain. This can help in tracking the journey of drugs from raw materials to the final product, reducing the risk of counterfeiting and ensuring quality. AI, on the other hand, can optimize various processes, such as drug discovery, clinical trials, and supply chain logistics. By analyzing vast amounts of data, AI can identify patterns, predict trends, and make informed decisions. This can accelerate drug development, improve manufacturing efficiency, and optimize inventory management.   The integration of blockchain and AI can create a powerful synergy, leading to significant improvements in the pharmaceutical supply chain. This includes enhanced patient safety, reduced costs, and faster time-to-market for new drugs. The presentation provides a concise view of the health care supply chain processes and discusses AI patterns such as RAG, GAM and Fine-Tuning methods such as LoRA and QLoRa that can help in building trust in the supply chain.

Each year Blockchain and Healthcare Today reaches out to journal board members, annual ConV2X Symposium speakers and ecosystem subject matter experts to share their near term views and perspectives for blockchain technology advances in healthcare. Representing perspectives from Asia, Europe and North America, the article presents insights into where authors anticipate market opportunities and gaps that should be addressed for regional and global collaboration, governance and efficiency for the year 2022.